Article info

Short report
Alzheimer’s disease marker phospho-tau181 is not elevated in the first year after moderate-to-severe TBI

Authors

  • Neil Graham Brain Sciences, Imperial College London, London, UK UK Dementia Research Institute Centre for Care Research and Technology, Imperial College London, London, UK PubMed articlesGoogle scholar articles
  • Karl Zimmerman Brain Sciences, Imperial College London, London, UK UK Dementia Research Institute Centre for Care Research and Technology, Imperial College London, London, UK PubMed articlesGoogle scholar articles
  • Amanda J Heslegrave UK Dementia Research Institute, University College London, London, UK PubMed articlesGoogle scholar articles
  • Ashvini Keshavan Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK PubMed articlesGoogle scholar articles
  • Federico Moro Laboratory of Acute Brain Injury and Neuroprotection, Department of Acute Brain and Cardiovascular Injury, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy Dipartimento di Anestesia e Rianimazione, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy PubMed articlesGoogle scholar articles
  • Samia Abed-Maillard Neuroscience Critical Care Research Group, Department of Intensive Care Medicine, CHUV Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland PubMed articlesGoogle scholar articles
  • Adriano Bernini Department of Clinical Neurosciences, CHUV Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland PubMed articlesGoogle scholar articles
  • Vincent Dunet Department of Medical Radiology, CHUV Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland PubMed articlesGoogle scholar articles
  • Elena Garbero Laboratory of Clinical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Italy PubMed articlesGoogle scholar articles
  • Giovanni Nattino Laboratory of Clinical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Italy PubMed articlesGoogle scholar articles
  • Arturo Chieregato Terapia Intensiva ad indirizzo Neurologico & Neurochirurgico, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy PubMed articlesGoogle scholar articles
  • Enrico Fainardi Department of Experimental and Clinical Sciences, Careggi University Hospital and University of Firenze, Florence, Italy PubMed articlesGoogle scholar articles
  • Camelia Baciu Terapia Intensiva ad indirizzo Neurologico & Neurochirurgico, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy PubMed articlesGoogle scholar articles
  • Primoz Gradisek Clinical Department of Anaesthesiology and Intensive Therapy, University Medical Center, Ljubljana, Slovenia PubMed articlesGoogle scholar articles
  • Sandra Magnoni Department of Anesthesia and Intensive Care, Santa Chiara Hospital, Trento, Italy PubMed articlesGoogle scholar articles
  • Mauro Oddo Neuroscience Critical Care Research Group, Department of Intensive Care Medicine, CHUV Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland Directorate for Innovation and Clinical Research, CHUV Lausanne University Hospital, Lausanne, Switzerland PubMed articlesGoogle scholar articles
  • Guido Bertolini Laboratory of Clinical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, Italy PubMed articlesGoogle scholar articles
  • Jonathan M Schott UK Dementia Research Institute, University College London, London, UK Dementia Research Centre and Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK PubMed articlesGoogle scholar articles
  • Henrik Zetterberg UK Dementia Research Institute, University College London, London, UK Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden PubMed articlesGoogle scholar articles
  • David Sharp Brain Sciences, Imperial College London, London, UK UK Dementia Research Institute Centre for Care Research and Technology, Imperial College London, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr David Sharp, Department of Brain Sciences, Imperial College London, London, SW7 2BX, UK; david.sharp{at}imperial.ac.uk
View Full Text

Citation

Graham N, Zimmerman K, Heslegrave AJ, et al
Alzheimer’s disease marker phospho-tau181 is not elevated in the first year after moderate-to-severe TBI

Publication history

  • Received May 17, 2023
  • Accepted September 19, 2023
  • First published October 13, 2023.
Online issue publication 
March 13, 2024

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.